Science Daily - Heart Disease

NOVEMBER 18, 2024

This new insight into the flow of fats through the body points to new therapeutic targets for mitigating diseases like ASCVD, non-alcoholic fatty liver disease, obesity, diabetes, peripheral neuropathy, and neurodegeneration.

Cardiovascular Disease 95

Cardiovascular Disease Cholesterol Obesity Diabetes 95

Cardiovascular Diabetology

SEPTEMBER 15, 2024

Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. During the 4.22-year

Obesity 98

Obesity Heart Failure Diabetes Cardiomyopathy 98

Cardiovascular Diabetology

SEPTEMBER 11, 2024

Cardiovascular disease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.

Obesity 130

Obesity Risk Factors Cardiovascular Disease Diabetes 130

Cardiovascular Diabetology

JUNE 5, 2024

Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on.

Cardiovascular Disease 59

Cardiovascular Disease Obesity Research 59

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Science Daily - Heart Disease

SEPTEMBER 23, 2024

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.

Medicare 131

Medicare Obesity Cardiovascular Disease Diabetes 131

American College of Cardiology

SEPTEMBER 11, 2024

The following are key points to remember from a European Society of Cardiology (ESC) clinical consensus statement on obesity and cardiovascular disease (CVD).

Obesity 70

Obesity Cardiovascular Disease Article 70

Circulation

MAY 20, 2024

Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Circulation, Ahead of Print.

Obesity 78

Obesity Public Health Research Cardiovascular Disease 78

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Despite its known correlations with risk of cardiovascular disease, awareness and testing for Lipoprotein (a) lags that of other serological markers with estimates that less than 1% of the US population have undergone screening.

Cardiovascular Disease 52

Cardiovascular Disease Biomarkers Obesity Outcomes 52

Journal of the American Heart Association

FEBRUARY 14, 2024

Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

Medical Xpress - Cardiology

APRIL 7, 2025

The five classic risk factors for cardiovascular disease are well knownsmoking, high blood pressure, high cholesterol, diabetes, and underweight or overweight/obesity. All increase the likelihood of heart ailments down the road.

Risk Factors 98

Risk Factors Blood Pressure Cholesterol Obesity 98

American College of Cardiology

JANUARY 8, 2024

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 70

Obesity Atrial Fibrillation Heart Failure Risk Factors 70

Med Page Today

NOVEMBER 26, 2024

(MedPage Today) -- Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Cardiovascular risk and obesity had the strongest relationship with lower gray matter volume in men between. Biobank data showed.

Obesity 110

Obesity Cardiovascular Disease 110

Cardiometabolic Health Congress

JANUARY 16, 2025

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. School-Based Interventions: Creating Healthy Habits Early Programs that limit sugar-sweetened beverages and increase physical education very likely reduce childhood obesity.

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. and Susan F. to 61% of the U.S.

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Circulation

JUNE 4, 2024

We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 26.8%) and obesity (43.1% Prevalences of coronary disease (7.8% in 2020 to 61.0% Diabetes (16.3%

Risk Factors 81

Risk Factors Cardiovascular Disease Stroke Strokes 81

The New England Journal of Medicine

NOVEMBER 10, 2023

Overweight and obesity have reached epidemic proportions, affecting more than 70% of the U.S. 1 In addition to numerous health consequences, obesity contributes to cardiovascular disease indirectly through the development of risk factors and directly through various biologic mechanisms.2

Obesity 40

Obesity Cardiovascular Disease Risk Factors 40

American College of Cardiology

JANUARY 21, 2025

Overweight and obesity are common in patients with heterozygous familial hypercholesterolemia (HeFH) and are associated with a greater risk of atherosclerotic cardiovascular disease (ASCVD) starting in childhood and regardless of LDL-C level and lipid-lowering medication, according to a cross-sectional analysis published Jan.

Obesity 54

Obesity Cardiovascular Disease Article 54

Medical Xpress - Cardiology

APRIL 2, 2024

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease.

Heart Disease 104

Heart Disease Obesity Cardiovascular Disease Diabetes 104

Medical Xpress - Cardiology

JULY 9, 2024

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.

Obesity 52

Obesity Cardiovascular Disease Diabetes 52

Cardiovascular Diabetology

JANUARY 23, 2025

Obesity, a major risk factor for cardiovascular disease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.

Obesity 52

Obesity Risk Factors Cardiovascular Disease Hypertension 52

Cardiovascular Diabetology

JULY 10, 2024

The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyc.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Cardiovascular Diabetology

MAY 28, 2024

Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

years; p  < 0.001), had more cardiovascular risk factors, target organ damage and cardiovascular disease (CVD) in comparison with those without hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Conclusions About half of patients attended in primary care settings have hypertension in Spain.

Blood Pressure 134

Blood Pressure Hypertension Obesity Risk Factors 134

Cardiovascular Diabetology

JANUARY 7, 2025

Among hypertensive cohorts across different nations, the relationship between the triglyceride-glucose index (TyG) and its conjunction with obesity metrics in relation to cardiovascular disease (CVD) incidence.

Obesity 52

Obesity Hypertension Cardiovascular Disease Research 52

CardiacWire

MAY 8, 2024

A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Journal of Clinical Investigation - Cardiology

DECEMBER 15, 2023

Metabolic syndrome, today affecting more than 20% of the US population, is a group of 5 conditions that often coexist and that strongly predispose to cardiovascular disease. How these conditions are linked mechanistically remains unclear, especially two of these: obesity and elevated blood pressure.

Blood Pressure 105

Blood Pressure Obesity Pharmacology Diet 105

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

Non-alcoholic fatty liver disease (NAFLD), now known as metabolic-associated steatotic liver disease (MASLD), is the most common liver disease worldwide, with a prevalence of 38%. In these patients, cardiovascular disease (CVD) is the number one cause of mortality rather than liver disease.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Risk Factors 52

Journal of the American Heart Association

DECEMBER 29, 2023

Multivariable logistic models evaluated associations of RARs with prevalent CVD, hypertension, obesity, and central adiposity. Participants (mean age, 49 years) in the highest versus lowest tertile of relative amplitude (greater circadian rhythmicity) had 39% to 62% lower odds of prevalent CVD, hypertension, obesity, and central adiposity.

Obesity 40

Obesity Cardiovascular Disease Hypertension 40

HeartRhythm

MARCH 31, 2025

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown to improve cardiovascular outcomes in obese patients with cardiovascular disease. However, their effects on patients undergoing ventricular tachycardia (VT) ablation remain unclear.

Obesity 40

Obesity Ablation Outcomes Tachycardia 40

Medical Xpress - Cardiology

DECEMBER 18, 2024

Cardiovascular disease (CVD) is a critical public health concern, with risk factors such as high blood pressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.

Blood Pressure 75

Blood Pressure Public Health Cholesterol Obesity 75

Dr. Paddy Barrett

DECEMBER 13, 2024

When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Trends in the number of obese and severely obese people by region. Rates of obesity have tripled in the last 60 years. But only moderately.

Heart Disease 98

Heart Disease BMI Diabetes Cardiovascular Disease 98

Open Heart

MAY 23, 2024

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Multiple logistic regression analysis was used to evaluate the impact of heart failure on the risk of pre-eclampsia, with adjustment for established risk factors and other cardiovascular diseases.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

Journal of the American Heart Association

APRIL 16, 2025

BackgroundHypothalamic gliosis is mechanistically linked to obesity and insulin resistance in rodent models. Journal of the American Heart Association, Ahead of Print. Our results highlight the need to consider central nervous system mechanisms to understand and improve cardiometabolic health.

Risk Factors 40

Risk Factors Cardiovascular Disease Cholesterol Heart Disease 40

The British Journal of Cardiology

AUGUST 6, 2024

Obesity is a global pandemic and is a recognised risk factor for cardiovascular diseases. Therefore, we conducted an observational study with a cohort of 196 participants, comparing various echocardiographic parameters in normal weight individuals and those who were overweight or obese but had no other risk factors.

Obesity 40

Obesity Risk Factors Cardiovascular Disease Cardiac Function 40

DAIC

MARCH 26, 2024

24 theme of Cardiovascular Care for All, we will highlight our commitment to underserved populations and present subset analyses in women and Hispanic/Latinx patients as well as in patients with obesity." "Complementing the ACC.24

Outcomes 105

Outcomes Obesity Cardiovascular Disease Atherosclerosis 105

The New England Journal of Medicine

NOVEMBER 10, 2023

In a trial in patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8

Obesity 40

Obesity Diabetes Cardiovascular Disease Outcomes 40